Welcome to the community clinical trial public home page
The European Medicines Agency has launched a new version of the European Clinical Trials Database (EudraCT). This new version, EudraCT V10, marks the final step of a process through which summary clinical trial results will be made publicly available through the EU Clinical Trials Register (EU CTR).
Sponsors’ representatives are recommended to register with EudraCT in order to become results users and before they can log into EudraCT. The registration process is described in the help and is accessed on the login page.
Eudra CT statistics for February are now available and can be viewed here.
Eudra CT statistics for December are now available and can be viewed here
Q&A for Dec 16 2014 session and the training session for stakeholders CT results for EudraCT V10 are available and can be found here
EudraCT statistics for October and November are now available and can be viewed here
The EudraCT V10 - Q&A for 19 Sept 2014 session and the training session for stakeholders CT results for EudraCT V10 are available and can be found here
EMA launches EudraCT result training environment
The EMA launched the EudraCT result training environment 1 August 2014. This application is aimed at representatives of sponsors and sponsor-investigators who want to familiarise themselves and get a better understanding in the preparation and posting of trials results in EudraCT. Further information can be found on the EudraCT result training environment home page.
EudraCT statistics for July are now available and can be viewed here
The European Medicines Agency has moved to
30 Churchill Place | Canary Wharf | London E14 5EU | United Kingdom
The presentation Getting started with EudraCT to prepare and post results has been updated to reflect the additional option of how to request an assignment based on protocol data.
EudraCT version 10 includes, and allows the following:
Create a EudraCT numberBefore any functionality of EudraCT can be used for a given clinical trial, a EudraCT number must be created in order to provide a unique reference for that trial.
Third country data providers can:
Results users can: